Cagrilintide is an extended-performing amylin receptor agonist formulated by Novo Nordisk for body weight management and metabolic well being. It mimics the action of Normally occurring amylin hormone, which is co-secreted with insulin from pancreatic beta cells.→ Lessen reliance on willpower: Functions with your body’s signaling units as oppos